Thyroid Cancer Diagnosis and Treatment
Thyroid Cancer Diagnosis and Treatment is a research topic within Endocrinology, Diabetes and Metabolism. Science Explorer counts 43k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management, diagnosis, and molecular genetics of thyroid cancer, including differentiated and medullary thyroid carcinoma. It covers topics such as the management guidelines for thyroid nodules, the role of BRAF mutation in papillary thyroid carcinoma, ultrasound imaging for thyroid nodules, and the use of radioactive iodine therapy. The cluster also discusses the molecular pathogenesis and genetic alterations associated with thyroid cancer.
- Thyroid Nodules
- Differentiated Thyroid Cancer
- Management Guidelines
- Thyroid Carcinoma
- BRAF Mutation
- Ultrasound
- Radioactive Iodine Therapy
- Molecular Genetics
- Medullary Thyroid Cancer
- Fine-Needle Aspiration
- Research works
- 43k fractional, since 1950
- In the world top 10%
- 4.3k per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +8% the tick is no change
- Largest producer
China
35% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Thyroid Cancer Diagnosis and Treatment research?
By volume, China and the United States publish the most (2.3k and 1.6k works in 2022-now).
By volume, 2022-now
- 1
China 2.3k works
- 2
United States 1.6k works
- 3
India 585 works
- 4
Italy 439 works
- 5
Türkiye 351 works
- 6
South Korea 349 works
- 7
Japan 297 works
- 8
Germany 216 works
- 9
United Kingdom 207 works
- 10
France 190 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Thyroid Cancer Diagnosis and Treatment research?
By volume in 2022-now, Shanghai Jiao Tong University publishes the most Thyroid Cancer Diagnosis and Treatment research, followed by Harvard University and Sichuan University.
By volume, 2022-now
- 1
Shanghai Jiao Tong University
China 86 works
- 2
Harvard University
United States 84 works
- 3
Sichuan University
China 75 works
- 4
Sun Yat-sen University
China 67 works
- 5
Chinese Academy of Medical Sciences & Peking Union Medical College
China 66 works
- 6
China Medical University
China 58 works
- 7
Capital Medical University
China 51 works
- 8
All India Institute of Medical Sciences
India 51 works
- 9
Zhejiang University
China 50 works
- 10
Seoul National University
South Korea 47 works
Who are the leading researchers in Thyroid Cancer Diagnosis and Treatment?
The most-cited researchers publishing on Thyroid Cancer Diagnosis and Treatment include Ahmedin Jemal, Freddie Bray and Zhong Lin Wang.
- 1
Ahmedin Jemal
United States 761k citations
- 2
Freddie Bray
France 550k citations
- 3
Zhong Lin Wang
United States 491k citations
- 4
George Davey Smith
United Kingdom 435k citations
- 5
Gad A. Getz
United States 364k citations
- 6
Hermann Brenner
Germany 343k citations
- 7
Emelia J. Benjamin
United States 341k citations
- 8
Jun Wang
China 340k citations
- 9
Graeme J. Hankey
Australia 316k citations
- 10
Gordon Henry Guyatt
Canada 315k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Thyroid Cancer Diagnosis and Treatment research done?
The largest centres of Thyroid Cancer Diagnosis and Treatment research in 2022-now are Beijing (China), Shanghai (China), Seoul (South Korea) and Hangzhou (China).
Where is the best place to study Thyroid Cancer Diagnosis and Treatment?
Among universities, judged by research, Harvard University, China Medical University and Sun Yat-sen University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Thyroid Cancer Diagnosis and Treatment, country by countryIs Thyroid Cancer Diagnosis and Treatment research growing?
Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Thyroid Cancer Diagnosis and Treatment.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Thyroid Cancer Diagnosis and Treatment as a percentage of every work published that year, 0.038% in 2024.
Fractional works of Thyroid Cancer Diagnosis and Treatment over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Thyroid Cancer Diagnosis and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.